PTPI · Petros Pharmaceuticals, Inc. · Executive Compensation
$0.05
-0.02 (-28.79%)
At close · May 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the Company does not have sufficient resources to fund its operations for the next twelve months from the date of this filing, management has substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$169,489
Shares
42.37M
Volume · May 22
10.28M
Avg daily vol (16 sessions)
38.33M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Fady Boctor | President and Chief Commercial Officer | $875,096 |
| Mitchell Arnold | Vice President of Finance and Chief Accounting Officer | $488,253 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Fady Boctor | President and Chief Commercial Officer | $682,209 |
| Mitchell Arnold | Vice President of Finance and Chief Accounting Officer | $407,014 |
| Andrew Gesek | Former President, Timm Medical | $135,796 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Fady Boctor | President and Chief Commercial Officer | $1,177,821 |
| Andrew Gesek | Former President, Timm Medical | $545,388 |
| Mitchell Arnold | Vice President of Finance and Chief Accounting Officer | $497,584 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Fady Boctor | President and Chief Commercial Officer | $467,850 |
| Keith Lavan | Chief Financial Officer | $462,458 |
| Andrew Gesek | President, TIMM Medical | $407,423 |
| Mitchell Arnold | Vice President of Finance and Chief Accounting Officer | $354,634 |
| Greg Ford | Chief Executive Officer | $252,700 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Andrew Gesek | President, TIMM Medical | $604,937 |
| Greg Ford | Chief Executive Officer | $450,399 |
| Keith Lavan | Chief Financial Officer | $413,302 |
| Fady Boctor | President and Chief Commercial Officer | $339,745 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert Weinstein | Chief Accounting Officer, Principal Financial Officer, and Principal Accounting Officer | Resigned | 2026-09-30 |
| Fady Boctor | President and Chief Commercial Officer | Terminated | 2026-09-30 |
| Wayne R. Walker | Director | Resigned | 2026-09-30 |
| Bruce T. Bernstein | Director | Resigned | 2026-09-30 |
| Joshua N. Silverman | Executive Chairman | Resigned | 2026-09-30 |
| Robert Weinstein | Principal Financial Officer | Appointed | 2026-06-18 |
| Robert Weinstein | Chief Accounting Officer | Appointed | 2026-06-18 |
| Greg Bradley | director | Resigned | 2024-10-04 |
| John Shulman | director | Resigned | 2024-10-04 |
Leadership
- Greg Ford CEO
- Keith Lavan CFO
- Mitchell Arnold CFO, Chief Accounting Officer
- Robert Weinstein CFO